Baxter International Inc. (NYSE: BAX) stock was boosted nearly 10% to a 52-week high of $75.68 intraday Thursday after the healthcare giant announced it's splitting into two separate companies.
The two new entities will include one focused on developing and marketing biopharmaceuticals and one concentrated on medical products. The split, expected to be completed by mid-2015, will be a tax-free distribution to Baxter shareholders.